
Pharma Weekly Updates in a Quick, 2-Minute Read.
| Platform | Pricing | Only free issues | Publishes | Weekly | |
|---|---|---|---|---|---|
| Issues | 155 | Founded | 2 years ago | Last Issue | 2 days ago |
| Active | |||||

🟢 FDA approved AstraZeneca’s Baxfendy for resistant hypertension, the 1st novel blood-pressure mechanism in 2 decades with multibillion-dollar annual sales potential.
🚨 World Health Organization raised its 2nd-highest international alert...
🤝 Bristol Myers Squibb signed a $15.2B broad licensing deal with Jiangsu Hengrui covering 13 early-stage oncology, hematology, and immunology programs.
🏛️ FDA Commissioner Marty Makary has departed, and acting drug center head Tracy Beth...
🤝 Angelini Pharma will acquire Catalyst Pharmaceuticals, Inc. for about $4.1B, gaining rare neurology drugs and a U.S. commercial platform.
🤝 UCB will acquire Candid Therapeutics for up to $2.2B, adding a promising autoimmune disease tre...
📈 Veradermics’ oral minoxidil pill met the main goal in a Phase 3 baldness trial, potentially becoming the 1st new hair-loss pill in 30 years - stock up +60%.
🤝 SUN PHARMA will acquire Organon for $11.75B, adding a broad women’s health a...
🤝 Eli Lilly and Company will acquire Kelonia Therapeutics for up to $7B, gaining an in vivo CAR-T therapy for multiple myeloma.
💰 Kailera Therapeutics raised $625M in a blockbuster IPO, one of biotech’s largest ever, to fund late-sta...
Subscribers, engagement, traffic and sponsorship for \ud83d\udd2c Latest Pharma Industry Updates.
| Subscribers | Engagement | 69 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #230 |
The writers behind this newsletter.
Pharma Senior Market Analyst providing weekly updates about the Life science industry.
You can find recent issues that have been published by this newsletter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to this newsletter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch this newsletter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact this newsletter using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like this newsletter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.